The firm’s performance stems from a strategy that integrates robust governance with digital transformation. By embedding quality management directly into shopfloor operations, the company aims to minimize errors and enhance manufacturing precision. Central to this effort is the RESOLVE program, which enforces right-first-time execution through concurrent batch record reviews and increased quality ownership at the site level.
Technological adoption has played a critical role in sustaining these outcomes. The deployment of eLab has digitized quality control laboratories, while exForms facilitates GxP compliance and documentation accessibility. Furthermore, the company has introduced iAssist, a human-in-the-loop AI tool designed to accelerate investigations and improve output consistency. According to Chief Quality Officer Rashida Najmi, these measures are designed to ensure that quality is built into daily operations. This disciplined approach is intended to provide the reliability required by global partners who depend on the company for complex drug development and manufacturing services across North America, Europe, and Asia.
Comments (0)
No comments yet. Be the first!